---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Verge HealthTech Fund

🌎 verge.fund

Verge HealthTech Fund is an investment management firm based in Singapore that focuses on venture capital investments in the health tech sector. The fund seeks to support founders globally who are developing transformative healthcare technologies, investing at the earliest stages, and partnering with them to create innovative solutions that enhance healthcare accessibility.

---

Updates as of Sep 11, 2024

• Verge HealthTech Fund's portfolio company RetiSpec closed $10M USD to advance commercialization of its AI-driven eye test for Alzheimer's detection.
• Verge HealthTech Fund led a €1.65 million seed funding round for Hello Inside, a startup focused on women's metabolic health using CGM technology.
• Verge HealthTech Fund invested in BrainCapture to revolutionize neurological diagnostics, according to Sigvards Krongorns, Associate at Verge HealthTech Fund.
• Verge HealthTech Fund's portfolio company Health2Sync partners with Merdury Biopharmaceutical to accelerate clinical trials for oral semaglutide using Health2Sync's digital platform and patient network in Taiwan.
• Scarlett Chen, Managing Partner at Verge HealthTech Fund, will speak at the Invest Hong Kong MedTech forum on September 9th.

• Verge HealthTech Fund will participate in the Singapore Week of Innovation and Technology (SWITCH) 2024 at Marina Bay Sands from 28 to 30 October.

---

Did you find it useful?

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.